Valuation (28%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | N/A | 36.72 |
| PEG Ratio (TTM) | N/A | 1.40 |
| P/S Ratio (TTM) | N/A | 3.67 |
| P/B Ratio (TTM) | N/A | 3.21 |
| P/FCF Ratio (TTM) | 0.01 | -22.09 |
| Price to 5YR AVG Earnings Ratio | N/A | 49.34 |
| Price to 5YR AVG FCF Ratio | 0.07 | 35.15 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | N/A | 1.54% |
| ROE (TTM) | N/A | 313.87% |
| Net Profit Margin (TTM) | N/A | 1.83% |
| ROIC 5YR AVG | N/A | 2.32% |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | N/A | N/A | N/A |
| Revenue | -25.00% | N/A | N/A |
| Net Income | N/A | N/A | N/A |
| Cash Flow | 296.37% | N/A | N/A |
Health (30%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.49 | 3.72 |
| Quick Ratio (TTM) | 2.49 | 3.70 |
| D/E Ratio (TTM) | N/A | 1.06 |
| Interest Coverage (TTM) | N/A | 11.64 |
| Piotroski F-Score | 5 | 5 |
| Altman Z-Score | 0.10 | 4.03 |
| LTL to 5YR AVG FCF | N/A | 51.67 |
| Shares Outstanding Growth 5YR AVG | N/A | 24.52% |